Dsm IP Assets B.v.

Genomatica, Inc.

Evonik Degussa Gmbh

Evonik Industries Ag

Centrient Pharmaceuticals Netherlands B.v.

Dsm Sinochem Pharmaceuticals Netherlands B.v.

Cosmoferm B.v.

Marco Alexander Van Den Berg

Steffen Schaffer

Manoj N Kumar

Jan Metske Van Der Laan

Paul Klaassen

Viktor Marius Boer

Liang Wu

Stefaan Marie Andre De Wildeman

Axel Christoph Trefzer

Petrus Jacobus Theodorus Dekker

Bianca Elisabeth Maria Gielesen

Geert Bruggeman

Hendrik Arie Schols

Adriana Marina Riemens

Paulus De Vos

Neha Mohan Sahasrabudhe

Jan Scholte

Lingmin Tian

Bernadette Theresia Morel

Anton Johannes Scheurink

Alrik Pieter Los

Cornelis Maria Jacobus Sagt

Robbertus Antonius Damveld

Margot Elisabeth Francoise Schooneveld-Bergmans

Priscilla Zwartjens

Bernard Meijrink

Roelof Ary Lans Bovenberg

Remko Tsjibbe Winter

Adrianus Wilhelmus Hermanus Vollebregt

Monica Diana Vlasie

Brenda Vonk

Hugo Streekstra

Thomas Hueller

Marcus Hans

Adam G Lawrence

Arnold Jacob Mattieu Driessen

Elaheh Jamalzadeh

Samuel Adrianus Maria Ruinard

Erik De Vroom

Erik Martinus Adrianus Maria Bruininx

Daniel Boergel

Erik Martinus Andrianus Maria Bruininx

Marcella Katharina Madern

Jeroen Gerben Nijland

Joshua Trueheart

Viktor Boer

Martin Lehmann

Stefaan Marie André De Wildeman

Manoj Kumar

Joshua Truehart

Lourina Madeleine Leonie Raamsdonk

Roeland Christiaan Roel Vollinga

John David Sutherland

The present invention describes a process for modifying a sweet protein or a taste modifying protein, comprising incubating a sweet protein solution or a taste modifying protein solution with a peptidyl arginine deiminase (PAD).

Use of peptidylarginine deiminase to obtain improved sweet protein

The present invention relates to a method for producing a flavour composition comprising providing a slurry of yeast cell walls and contacting the slurry of yeast cell walls with a glucanase and with an endoprotease, followed by separating a liquid fraction by solid/liquid separation to provide the liquid flavour composition.

Yeast cell wall derived flavour

The present invention relates to a method for preparing an adipate ester or thioester. The invention further relates to a method for preparing adipic acid from said ester or thioester. Further the invention provides a number of methods for preparing an intermediate for said ester or thioester. Further the invention relates to a method for preparing 6-amino caproic acid (6-ACA), a method for preparing 5-formyl valeric acid (5-FVA), and a method for preparing caprolactam. Further, the invention relates to a host cell for use in a method according to the invention.

Adipate (ester or thioester) synthesis

The present invention relates to a method for the enzymatic reduction of cystine to cysteine comprising contacting cystine with a reduction solution comprising: (i) an active glutathione reductase (EC1.8.1.7); (ii) a cofactor; and (iii) glutathione; and recovering a cysteine comprising composition, wherein the reduction solution has a pH of at least 6 during contacting with cystine.

Enzymatic reduction of cystine

Methods for managing the body mass index, the body fat percentage and/or the distribution of fat storage sites of humans are provided, and more particularly the use of food compositions for managing the body mass index, the body fat percentage and/or the distribution of fat storage sites by administering to a human in need of managing body mass index, body fat percentage and/or distribution of fat storage sites an effective amount of a food formulation comprised of an esterified pectin having a degree of esterification (DE) of less than 65%.

Food compositions for managing body weight

This invention relates generally to compositions and methods for combating inflammatory disease and particularly to the use of food and/or feed compositions for preventing, reducing and/or treating inflammatory disorders, diseases, or discomforts, wherein the compositions comprising at least one specific pectin.

Food and/or feed compositions for preventing and treating inflammatory diseases

The present invention relates to polynucleotide sequences which enable a polynucleotide control sequence, such as a promoter, to direct expression in a wide range of industrially relevant species, both prokaryotes and eukaryotes. When the polynucleotide sequences of the invention are applied in combination with selection marker genes it is possible to perform selectable cloning in a laboratory host and use the same construct in the final host.

Multi-species polynucleotide control sequences

The present invention relates to a method for increasing the degree of glycosylation of a composition comprising steviol glycosides, which method comprises: a. contacting said composition comprising steviol glycosides with a recombinant microorganism, a cell free extract derived from such a microorganism or an enzyme preparation derived from either thereof; and b. thereby to increase the degree of glycosylation of the composition comprising steviol glycosides, wherein the recombinant microorganism comprises one or more nucleotide sequence(s) encoding: a polypeptide having ent-copalyl pyrophosphate synthase activity; a polypeptide having ent-Kaurene synthase activity; a polypeptide having ent-Kaurene oxidase activity; a polypeptide having kaurenoic acid 13-hydroxylase activity; and one or more polypeptides having UDP-glucosyltransferase activity whereby expression of the nucleotide sequence(s) confer(s) on the microorganism the ability to produce at least one steviol glycoside. The present invention also relates to a composition comprising steviol glycosides obtainable by such a method.

Method for increasing glycosylation of a composition comprising steviol glycosides

The present invention relates to a method for increasing the efficiency of targeted integration of a polynucleotide to a pre-determined site into the genome of a filamentous fungal cell with a preference for NHR, wherein said polynucleotide has a region of homology with said pre-determined site, comprising steering an integration pathway towards HR. The present invention also relates to a mutant filamentous fungus originating from a parent cell, said mutant having an HR pathway with elevated efficiency and/or an NHR pathway with a lowered efficiency and/or a NHR/HR ratio with decreased efficiency as compared to said HR and/or NHR efficiency and/or NHR/HR ratio of said parent cell under the same conditions.

Filamentous fungal mutants with improved homologous recombination efficiency

The present invention provides a method for the transfection of filamentous fungal cells, comprising providing a multitude of containers, filling into each container an amount of polymer needed for the transfection, filling the cells to be transfected as well as an aqueous solution of transfection reagent into each of the containers, incubating the resulting mixture, removing the transfection reagent from the incubated mixture; and selecting the cells which have been transformed, characterized in that the total volume of the incubating mixture is less than 1 ml per container. Furthermore, the present invention provides the use of transformed filamentous fungal cells for the production of proteins or metabolites.

High throughput transfection of filamentous fungi

The present invention provides microbial strains, in particular yeast strains, that produce at least 0.1 mg per g biomass dry weight of a sphingoid base. The present invention further provides a method to obtain sphingoid base-producing microbial strains comprising incubating a population of microbial cells in the presence of a suitable concentration of a toxin, selecting cells that are resistant against said toxin, and isolating cells out of the toxin-resistant cell population that produce at least 0.1 mg per g biomass dry weight of the sphingoid base of Formula I. Optionally, the method further comprises subjecting a population of toxin-resistant microbial cells that produce at least 0.1 mg per g biomass dry weight of the sphingoid base of Formula I to DNA-mediated transformation with a polynucleotide encoding an enzyme of the sphingolipid metabolic pathway. The present invention further provides a polypeptide having dihydroceramide desaturase activity obtainable form

Microbial strains producing sphingoid bases or derivatives thereof

Growing community of inventors

Poeldijk, Netherlands

Marco Alexander Van Den Berg